Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paracervical mepivacaine for pain control during office hysteroscopy
2021-001182-21Phase 4Active
- Sponsor
- Hospital Universitario Puerta de Hierro Majadahonda
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial comparing Paracervical mepivacaine 2% with Paracervical placebo (2 arms). Primary endpoint: Overall pain during office hysteroscopy. Started Jun 2021; status: active.
02
Drugs
mepivacaine
Beyond the preview
Go deeper on 2021-001182-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001182-21.